OccuLogix, Inc. dba TearLab Corporation today announced that the Company will immediately begin conducting business as TearLab Corporation and has changed its stock ticker symbols on the NASDAQ and Toronto Stock Exchange to TEAR and TLB, respectively. The official name change will be effective once stockholder approval is received.
Eric Donsky, CEO of TearLab Corporation, stated, ``Implementing the new name and ticker symbol enables us to align our corporate brand with our vision to become the leader in tear testing and biomarker analysis at the point-of-care.''
About OccuLogix, Inc. dba TearLab Corporation
OccuLogix dba TearLab Corporation (http://www.tearlab.com) is an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies (integrating one or several laboratory functions on a chip only millimeters in size) that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.
Contact:
Edelman
Investor Relations:
Mona J. Walsh
212-704-4598
mona.walsh@edelman.com
TearLab Corporation
Media Inquiries:
Tracy Puckett
404-797-5526
tpuckett@tearlab.com
via yahoo
Eric Donsky, CEO of TearLab Corporation, stated, ``Implementing the new name and ticker symbol enables us to align our corporate brand with our vision to become the leader in tear testing and biomarker analysis at the point-of-care.''
About OccuLogix, Inc. dba TearLab Corporation
OccuLogix dba TearLab Corporation (http://www.tearlab.com) is an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies (integrating one or several laboratory functions on a chip only millimeters in size) that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.
Contact:
Edelman
Investor Relations:
Mona J. Walsh
212-704-4598
mona.walsh@edelman.com
TearLab Corporation
Media Inquiries:
Tracy Puckett
404-797-5526
tpuckett@tearlab.com
via yahoo
0 comments:
Post a Comment